REVBW
Revelation Biosciences IncNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-4.77
Beta
-0.12
52W High
$0.02
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Revelation Biosciences Inc
Revelation Biosciences Inc is a pioneering biotechnology firm focused on creating innovative therapeutic solutions for respiratory diseases such as allergies and asthma. Utilizing its proprietary research platform, the company aims to tackle substantial unmet medical needs through its advanced R&D programs. With a robust pipeline of therapies and strategic partnerships across the industry, Revelation is adeptly positioned to maneuver through the complexities of regulatory frameworks, ultimately enhancing patient outcomes and delivering significant therapeutic advancements for those affected by respiratory conditions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-10.04M |
| Operating Margin | 0.00% |
| Return on Equity | -124.40% |
| Return on Assets | -66.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.32 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $3.44M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Data last updated: 7/9/2026